Meeting
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Understanding the peripheral cellular immunome in patients with breast cancer.
Authors
Karenia Landa
Duke University Hospital, Durham, NC
Karenia Landa, Eda Holl, Victoria Frazier, Eun-Sil Shelley Hwang, Smita Nair
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies
Sub Track
Humoral Immunity for Diagnosis and Therapy
Citation
J Clin Oncol 37, 2019 (suppl 8; abstr 7)
DOI
10.1200/JCO.2019.37.8_suppl.7
Abstract #
7
Poster Bd #
B5
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Phase 2 trial results of DN24-02, a HER2-targeted autologous cellular immunotherapy in HER2+ urothelial cancer patients (pts).
First Author: Dean F. Bajorin
Poster
2023 ASCO Annual Meeting
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
First Author: Kay T Yeung
Poster
2023 ASCO Annual Meeting
Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL.
First Author: Rebecca Arielle Shatsky
Poster
2019 ASCO Annual Meeting
No relationship of axillary total tumor load (TTL) by PCR (OSNA) in early breast cancer and local and distant clinical outcomes.
First Author: Jose Ales-Martinez